Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

12 March 2002

Evaluation of oxidative stress indices during treatment in pregnant women with intrauterine growth retardation.

Jacek Suzin, Agata Karowicz-Bilińska, Piotr Sieroszewski

Med Sci Monit 2002; 8(3): CR211-216 :: ID: 420889


BACKGROUND: We investigated treatment-related changes in oxidative stressindices in intrauterine growth retardation (IUGR) during pregnancy. Four parameters of cell membranedestruction were measured: malondialdehyde, Schiff bases, lipid peroxides, and conjugated dienes. MATERIAL/METHODS:The study population included pregnant women under treatment in the Department of Obstetrics and Gynecologyat the Medical University of Łódź in 1997-1999, divided into two groups: (I) - 30 healthy pregnantwomen, (II) - 31 pregnant women with a clinical and ultrasound diagnosis of IUGR. The course of treatmentconsisted of ten days of intravenous injections of cocarboxylase, Vitamin C, and solcoseryl as antioxidantfactors. The parameters of oxidative stress were measured on the first day of hospitalization, afterfive days of treatment, and on the 10th day of treatment. RESULTS: The mean value of MDA concentrationin Group I was 2.03, vs. 2.39 in Group II. The mean value of conjugated dienes was 2.40 in Group I and2.41 in Group II. The Schiff bases concentration in Group I was 8.03, as opposed to 8.83 in Group II.The concentration of lipid peroxides was 0.113 in Group I and 0.134 in Group II. We found that all theparameters of oxidative stress were higher in IUGR than in normal pregnancy. At the end of treatmenta decrease was observed in all oxidative stress parameters. CONCLUSIONS: IUGR is correlated with an increasein membrane damage parameters. Therapy for IUGR decreased the values of all indices of oxidative stress.

Keywords: Actihaemyl, Ascorbic Acid, Fetal Growth Retardation, Lipid Peroxidation, Pregnancy, Research Support, Non-U.S. Gov, Thiamine Pyrophosphate

Add Comment 0 Comments

545 6


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

01 Jun 2023 : Clinical Research  

Root Canal Numbers and Configurations in 1080 Permanent Canine Teeth in 270 Saudi Subjects Using Cone-Beam ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940472  

01 Jun 2023 : Clinical Research  

Internal Orifice Alloy Closure: A New Procedure for Treatment of Perianal Fistulizing Crohn’s Disease

Med Sci Monit In Press; DOI: 10.12659/MSM.940873  

01 Jun 2023 : Clinical Research  

Effectiveness of Needle Aspiration versus Surgical Excision for Symptomatic Synovial Cysts of the Hip: A Si...

Med Sci Monit In Press; DOI: 10.12659/MSM.940187  

01 Jun 2023 : Clinical Research  

Influence of Insulin Resistance on Diabetes Nephropathy

Med Sci Monit In Press; DOI: 10.12659/MSM.939482  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750